Nonadherence in patients with breast cancer receiving oral therapies

Clinical Journal of Oncology Nursing

Volumn 14, Issue 1, 2010, Pages 41-47

  Moore, Susan ^a  

^a MCG Oncology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; TAMOXIFEN;

AGE; ATTITUDE TO HEALTH; BREAST TUMOR; DISEASE COURSE; FEMALE; HUMAN; NURSING; ORAL DRUG ADMINISTRATION; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT EDUCATION; REVIEW; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; AGE FACTORS; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; DISEASE PROGRESSION; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MEDICATION ADHERENCE; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT EDUCATION AS TOPIC; TAMOXIFEN; TREATMENT OUTCOME;

EID: 79952115242     PISSN: 10921095     EISSN: 1538067X     Source Type: Journal    
DOI: 10.1188/10.CJON.41-47     Document Type: Article

References (51)

1. American Society on Aging & American Society of Consultant Pharmacists Foundation. (2006). Adult Meducation™ improving medication adherence in older adults. Retrieved from http://www.adultmeducation.com/downloads/Questions_You_Should_Ask.pdf
2. Atkins, L., & Fallowfield, L. (2006). Intentional and non-intentional non-adherence to medication amongst breast cancer patients. European Journal of Cancer, 42, 2271-2276. doi: 10.1016/j.ejca.2006.03.004
3. Barron, T.I., Connolly, R.M., Bennett, K., Feely, J., & Kennedy, M.J. (2007). Early discontinuation of tamoxifen. A lesson for oncologists. Cancer, 109, 832-839. doi: 10.1002/cncr.22485
4. Blasdel, C., & Bubalo, J. (2006). Adherence to oral cancer therapies: Meeting the challenge of new patient care needs. Retrieved from http://www.clinicaloncology.com/download/563SR-Novartis.pdf
5. Chan, M., Nicklason, F., & Vial, J.H. (2001). Adverse drug events as a cause of hospital admission in the elderly. Internal Medicine Journal, 31, 199-205. doi: 10.1046/j.1445-5994.2001.00044.x
6. Chia, L.R., Schlenk, E.A., & Dunbar-Jacob, J. (2006). Effect of personal and cultural beliefs on medication adherence in the elderly. Drugs and Aging, 23, 191-202. doi: 10.2165/00002512-200623030-00002
7. Claxton, A.J., Cramer, J., & Pierce, C. (2001). A systematic review of the associations between dose regimens and medication compliance. Clinical Therapeutics, 23, 1296-1310. doi: 10.1016/S0149-2918 (01)80109-0
8. Committee on Quality of Healthcare in America. (2000). To err is human: Building a safer health system. Washington, DC: National Academies Press.
9. Early Breast Cancer Trialists' Collaborative Group. (2005). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomized trials. Lancet, 365, 1687-1717. doi: 10.1016/S0140-6736(05) 66544-0
10. Ernst, F.R., & Grizzle, A.J. (2001). Drug-related morbidity and mortality: Updating the cost-of-illness model. Journal of the American Pharmacy Association, 41, 192-199. Retrieved from http://www.medscape.com/viewarticle/406716
11. Fallowfield, L., Atkins, L., Catt, S., Cox, A., Coxon, C., Langridge, C.I., Price, M. (2006). Patients' preference for administration of endocrine treatments by injection or tablets: Results from a study of women with breast cancer. Annals of Oncology, 17, 205-210. doi: 10.1093/annonc/mdj044
12. Fink, A.K., Gurwitz, J., Rakowski, W., Guadagnoli, E., & Silliman, R.A. (2004). Patient beliefs and tamoxifen discontinuance in older women with estrogen receptor-positive breast cancer. Journal of Clinical Oncology, 22, 3309-3315. doi: 10.1200/JCO.2004.11.064
13. ® (lapatinib) [Prescribing information]. Retrieved from http://us.gsk.com/products/assets/us_tykerb.pdf
14. Grunfeld, E.A., Hunter, M.S., Sikka, P., & Mittal, S. (2005). Adherence beliefs among breast cancer patients taking tamoxifen. Patient Education and Counseling, 59, 97-102. doi: 10.1016/j.pec.2004.10.005
15. Haynes, R.B., Ackloo, E., Sahota, N., McDonald, H.P., & Yao, X. (2008). Interventions for enhancing medication adherence. Cochrane Database of Systematic Reviews, 2, CD000011. doi: 10.1002/14651858.CD000011.pub3
16. Heidenreich, P.A. (2004). Patient adherence: The next frontier in quality improvement. American Journal of Medicine, 117, 130-132. doi: 10.1016/j.amjmed.2004.03.007
17. Kav, S., Johnson, J., Rittenberg, C., Fernadez-Ortega, P., Suominen, T., Olsen, P., Clark-Snow, R. (2008). Role of the nurse in patient education and follow-up of people receiving oral chemotherapy treatment: An international survey. Supportive Care in Cancer, 16, 1075-1083. doi: 10.1007/s00520-007-0377-x
18. Kennedy, J., Tuleu, I., & Mackay, K. (2008). Unfilled prescriptions of Medicare beneficiaries: Prevalence, reasons, and types of medicines prescribed. Journal of Managed Care Pharmacy 14, 553-560. Retrieved from http://www.amcp.org/data/jmcp/JMCPMaga_553-560.pdf
19. Kirk, M.C., & Hudis, C.A. (2008). Insight into barriers against optimal adherence to oral hormonal therapy in women with breast cancer. Clinical Breast Cancer, 8, 155-161. doi: 10.3816/CBC.2008.n.016
20. Kripalani, S., Yao, X., & Haynes, B. (2007). Interventions to enhance medication adherence in chronic medical conditions. A systematic review. Archives of Internal Medicine, 167, 540-550. doi: 10.1001/archinte.167.6.540
21. Kruk, M.E., & Schwalbe, N. (2006). The relation between intermittent dosing and adherence: Preliminary insights. Clinical Therapeutics, 28, 1989-1995. doi: 10.1016/j.clinthera.2006.12.011
22. LaFleur, J., & Oderda, G.M. (2004). Methods to measure patient compliance with medication regimens. Journal of Pain and Palliative Care Pharmacotherapy, 18, 81-87. Retrieved from http://informahealthcare.com/doi/abs/10.1080/J354v18n03_09
23. Lash, T.L., Fox, M.P., Westrup, J.L., Fink, A.K., & Silliman, R.A. (2006). Adherence to tamoxifen over the five-year course. Breast Cancer Research and Treatment, 99, 215-220.
24. Lawrence, D.B., Allison, W., Chen, J.C., & Demand, M. (2008). Improving medication adherence with a targeted, technology- driven disease management intervention. Disease Management, 11, 141-144. doi: 10.1089/dis.2007.0013
25. Lazarou, J., Pomeranz, B.H., & Corey, P.N. (1998). Incidence of adverse drug reactions in hospitalized patients. JAMA, 279, 1200-1205. doi: 10.1001/jama.279.15.1200
26. Lebovits, A.H., Strain, J.J., Schleifer, S.J., Tanaka, J.S., Bhardwaj, S., & Messe, M.R. (1990). Patient noncompliance with self-administered chemotherapy. Cancer, 65, 17-22. doi: 10.1002/1097-0142 (19900101)65:1<17::AID-CNCR2820650106>3.0.CO;2-I
27. MacLaughlin, E.J., Raehl, C.L., Treadway, A.K., Sterling, T.L., Zoller, D.P., & Bond, C.A. (2005). Assessing medication adherence in the elderly: Which tools to use in clinical practice? Drugs and Aging, 22, 231-255. doi: 10.2165/00002512-200522030-00005
28. Madden, M., Graves, A.J., Zhang, F., Adams, A.S., Briesacher, B.A., Ross-Degnan, D., Soumerai, S.B. (2008) Cost-related medication nonadherence and spending on basic needs following implementation of Medicare Part D. JAMA, 299, 1922-1928. doi: 10.1001/jama.299.16.1922
29. Merck Manual of Medical Information. (2008). Adherence to drug treatment. Retrieved from http://www.merck.com/mmhe/printsec02/ch016/ch016a.html
30. Miaskowski, C., Shockney, L., & Chlebowski, R.T. (2008). Adherence to oral endocrine therapy for breast cancer: A nursing perspective. Clinical Journal of Oncology Nursing, 12, 213-221. doi: 10.1188/08.CJON.213-221
31. Moore, S. (2007). Facilitating oral chemotherapy treatment and compliance through patient/family-focused education. Cancer Nursing, 30, 112-122. doi: 10.1097/01.NCC.0000265009.33053.2d
32. Moore, S.H. (2005). Capecitabine: Considerations for oncology nursing practice. Retrieved from http://www.oncologyreport.com/supplements/05s118.pdf
33. Moore, S.H. (2007). Managing treatment side effects in advanced breast cancer. Seminars in Oncology Nursing, 23(Suppl., 2), S23-S30. Retrieved from http://www.seminarsoncologynursing.com/article/S0749-2081(07)00092-7/abstract
34. Morris, L.S., & Schulz, R.M. (1993). Medication compliance: The patient's perspective. Clinical Therapeutics, 15, 593-606.
35. Murray, M.D., Morrow, D.G., Weiner, M., Clark, D.O., Tu, W., Deer, M.M., Weinberger, M. (2004). A conceptual framework to study medication adherence in older adults. American Journal of Geriatric Pharmacotherapy, 2, 36-43. doi: 10.1016/S1543 -5946 (04)90005-0
36. Murthy, V., Bharia, G., & Sarin, R (2002). Tamoxifen noncompliance: Does it matter? Lancet Oncology, 3, 654. doi: 10.1016/S1470-2045 (02)00895-1
37. Osterberg, L., & Blaschke, T. (2005). Adherence to medication. New England Journal of Medicine, 353, 487-497. doi: 10.1056/ NEJMra050100
38. Partridge, A.H., LaFountain, A., Mayer, E., Taylor, B.S., Winer, E., & Asnis-Alibozek, A. (2008). Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer. Journal of Clinical Oncology, 26, 556-562. doi: 10.1200/JCO.2007.11.5451
39. Partridge, A.H., Wang, P.S., Winer, E.P., & Avorn, J. (2003). Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. Journal of Clinical Oncology, 21, 602-606. doi: 10.1200/JCO.2003.07.071
40. Paterson, D.L., Swindells, S., & Mohr, J. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133, 21-31.
41. Peterson, A.M., Takiya, L., & Finley, R. (2003). Meta-analysis of trials of interventions to improve medication adherence. American Journal of Health System Pharmacy, 60, 657-665.
42. Ruddy, K., Mayer, E., & Partridge, A. (2009). Patient adherence and persistence with oral anticancer treatment. CA: A Cancer Journal for Clinicians, 59, 56-66. doi: 10.3322/caac.20004
43. Schwartz, K., Claxton, G., Martin, K., & Schmidt, C. (2009). Spending to survive: Cancer patients confront holes in the health insurance system. Retrieved from http://www.kff.org/insurance/insurance020509nr.cfm
44. Simpson, R.J. (2006). Challenges for improving medication adherence. JAMA, 296, 2614-2616. doi: 10.1001/jama.296.21.jed60074
45. Soumerai, S.B., Pierre-Jacques, M., Zhang, F., Ross-Degnan, D., Adams, A.S., Gurwitz, J., Safran, G. (2006). Cost-related medication nonadherence among elderly and disabled Medicare beneficiaries. Archives of Internal Medicine, 166, 1829-1835. doi: 10.1001/archinte.166.17.1829
46. Thompson, A.M., Dewar, J., Fahey, T., & McCowan, C. (2007). Association of poor adherence to prescribed tamoxifen with risk of death from breast cancer [Abstract 130]. Retrieved from http://www.asco.org/Abstracts+%26+Virtual+Meeting/Abstracts?&vmview=abst_detail_view&confID=52&abstractID=40326
47. van Eijken, M., Tsang, S., Wensing, M., de Smet, P.A., & Grol, R.P. (2003). Interventions to improve medication compliance in older patients living in the community: A systematic review of the literature. Drugs and Aging, 20, 229-240. doi: 10.2165/00002512 -200320030-00006
48. Vrijens, B., Gross, R., & Urquhart, J. (2005). The odds that clinically unrecognized poor or partial adherence confuses population pharmacokinetic/pharmacodynamic analyses. Basic Clinical Pharmacology and Toxicology, 96, 225-227. doi: 10.1111/j.1742 -7843.2005.pto960312.x
49. Waterhouse, D.M., Calzone, K.A., Mele, C., & Brenner, D.E. (1993). Adherence to oral tamoxifen: A comparison of patient self-report, pill counts, and microelectronic monitoring. Journal of Clinical Oncology, 11, 1189-1197.
50. Weingart, S.N., Brown, E., Bach, P.B., Eng, K., Johnson, S.A., Kuzel, T.M., Walters, R.S. (2008). NCCN task force report: Oral chemotherapy. Journal of the National Comprehensive Cancer Network, 6(Suppl., 3), S1-S14.
51. World Health Organization. (2003). Adherence to long-term therapies: Evidence for action. Retrieved from http://www.who.int/chp/knowledge/publications/adherence_report/en/index.html